Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

A biometrics merger
July 2019
SHARING OPTIONS:

CAMBRIDGE, Mass. & SEATTLE—Cytel Inc. and Axio Research recently announced plans to merge, a move that the companies say will “create the largest global biometrics organization focused on delivering advanced analytical solutions for the life-sciences industry.” Specific details about the merger were not disclosed, but once the transaction closes, the combined unit will operate under the Cytel brand. Axio will continue to provide its data monitoring committee services for clinical trials under the banner of “Axio, a Cytel company.” The merger combines Cytel's experience in innovative trial methodologies and analytics with Axio's position as a leader in data monitoring committee services and biostatistics solutions.
 
“We believe that better use of data will ultimately revolutionize drug development,” said Cytel CEO Joshua Schultz. “Our vision is to unite the combined expertise of our two companies to deliver powerful analytical solutions that address trial sponsors’ toughest drug development challenges and maximize the opportunities offered by emerging data sources."

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.